You searched for Antibody candidate - Page 18 of 69

Best in Biotech 8 May 2019

Top 10 Biotechs in Lausanne

…discontinuing two phase III trials testing AC Immune’s lead antibody drug candidate as an Alzheimer’s treatment. However, the candidate is still in an ongoing phase II trial for the prevention…

May 8, 2019 - 7 minutesmins - By David Cox

News and Trends 17 Oct 2022

Ophthalmology biopharma company Oculis combines with EBAC

…Other candidates In addition to these three clinical candidates, Oculis is engaged in several earlier preclinical development initiatives, including the evaluation of OCS-03 as a possible treatment for corneal neovascularization,…

October 17, 2022 - 5 minutesmins - By Jim Cornall

News and Trends 21 Jul 2016

Former uniQure and Evotec CEO pushes new viral candidate into Clinical Trials

Hookipa is starting its first clinical trial for a vaccine against human cytomegalovirus. This is the leading candidate of its platform for novel viral vectors, which promises to yield better…

July 21, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 21 Dec 2022

Poolbeg identifies new potential drug candidates for RSV infections

Poolbeg Pharma says it has successfully identified potential new drug candidates from its respiratory syncytial virus (RSV) artificial intelligence (AI) program with OneThree Biotech, Inc. Since initiating the collaboration in…

December 21, 2022 - 3 minutesmins - By Jim Cornall

In Depth 19 Mar 2025

Breast cancer treatments heat up: Five therapies poised to transform patient outcomes

…in 2023, in which BioNTech paid $55 million upfront for the rights to the candidate outside of greater China. The candidate in question is a bispecific antibody called BNT327 that…

March 19, 2025 - 11 minutesmins - By Willow Shah-Neville

News and Trends 21 Sep 2022

Poolbeg to investigate melioidosis vaccine candidate

Poolbeg Pharma has signed an exclusive agreement with University College Dublin (UCD) through NovaUCD, the university’s knowledge transfer office, for a late preclinical stage vaccine candidate for melioidosis, a disease…

September 21, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 10 May 2023

Scientists create first CRISPR-based drug candidate targeting the microbiome

A new CRISPR-based drug candidate targeting E. coli in the gut microbiome is in phase 1 clinical trials. According to a new paper published in Nature Biotechnology, it may improve…

May 10, 2023 - 6 minutesmins - By Jim Cornall

Best in Biotech 20 Feb 2024

Biotechs in the US Capital: seven key players based in Washington DC

…to specific genetic variants in the IGHMBP2 gene. The second candidate, VTR-297, is a novel topical antifungal candidate aimed at treating onychomycosis. This condition, affecting up to 14% of the…

February 20, 2024 - 9 minutesmins - By Jules Adam

News and Trends 1 Jul 2022

Companies come together in fight against Dengue Fever

…vaccine candidate. The agreement initially focuses on Emergex’s dengue vaccine candidate and also includes the shared development and commercialization of COVID-19 and Chikungunya vaccine candidates. Emergex’s Dengue and COVID-19 vaccine…

July 1, 2022 - 4 minutesmins - By Liza Laws

Best in Biotech 25 Jan 2024

Eight mental health biotech companies trying to make a difference to people’s lives

…get better faster. The company’s clinical pipeline includes novel drug candidates for depression, post-traumatic stress disorder (PTSD), schizophrenia, and other mental health conditions. It also has its own biomarker platform…

January 25, 2024 - 11 minutesmins - By Willow Shah-Neville

News and Trends 21 Mar 2025

Depression drug trials are failing—and placebos are to blame

…effect is,” the study read. Depression candidate Supernus’ SPN-820 fails in phase 2b clinical trial; Actinogen blames placebos This was seen with American biotech Supernus Pharmaceuticals’ depression candidate SPN-820, which…

March 21, 2025 - 9 minutesmins - By Roohi Mariam Peter

In Depth 30 Jul 2024

Why is the immunology and inflammation market suddenly attracting a wave of investment?

…biomedical advancements in the basic science of immunology combined with productizing therapeutic antibodies enabled the second wave. Here, doctors could finally direct an antibody at a defined immune target, allowing…

July 30, 2024 - 13 minutesmins - By Willow Shah-Neville

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

Top 10 Biotechs in Lausanne

Ophthalmology biopharma company Oculis combines with EBAC

Former uniQure and Evotec CEO pushes new viral candidate into Clinical Trials

Poolbeg identifies new potential drug candidates for RSV infections

Breast cancer treatments heat up: Five therapies poised to transform patient outcomes

Poolbeg to investigate melioidosis vaccine candidate

Scientists create first CRISPR-based drug candidate targeting the microbiome

Biotechs in the US Capital: seven key players based in Washington DC

Companies come together in fight against Dengue Fever

Eight mental health biotech companies trying to make a difference to people’s lives

Depression drug trials are failing—and placebos are to blame

Why is the immunology and inflammation market suddenly attracting a wave of investment?

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!